Abstract
Numerous studies have tested for associations between common polymorphisms of the angiotensin-converting enzyme gene and sporadic Alzheimer disease (SAD), but results have been inconclusive. Using meta-analysis, our study aimed to clarify the nature of the genetic risks contributed by the three polymorphisms (rs4291, rs4343, rs1800764) for developing SAD. Through searching of Pubmed, Embase, Alzgene and manually searching relevant references, a total of 14 articles with 26 independent studies were included. Odds ratios (ORs) with 95 % confidence intervals (CIs) were used to assess the strength of the association studies. The heterogeneity across the studies was tested, as was publication bias. We observed significant association between SNP rs4291 and SAD using allelic comparison (OR = 1.08, 95 % CI 1.03–1.14), homozygote comparison (OR = 1.16, 95 % CI 1.04–1.30) and the recessive model (OR = 1.10, 95 % CI 1.02–1.18). Association with SNP rs1800764 was revealed but it was not sufficiently robust to withstand the Benjamini–Hochberg method and stepdown Bonferroni correction. Significant association was not identified in the analysis for SNP rs4343. In subgroup analyses, the risk of SAD associated with SNP rs4291 appeared to be significant among Caucasians and in older cases (mean age ≥75 years). Our results confirmed a significant but modest association between SNP rs4291 and SAD susceptibility. Further study of the pathogenetic characteristics of this polymorphism and independent confirmation of the association in larger studies are warranted.
Similar content being viewed by others
References
Baghai TC, Binder EB, Schule C, Salyakina D, Eser D, Lucae S, Zwanzger P, Haberger C, Zill P, Ising M, Deiml T, Uhr M, Illig T, Wichmann HE, Modell S, Nothdurfter C, Holsboer F, Muller-Myhsok B, Moller HJ, Rupprecht R, Bondy B (2006) Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Mol Psychiatry 11(11):1003–1015. doi:10.1038/sj.mp.4001884
Belbin O, Brown K, Shi H, Medway C, Abraham R, Passmore P, Mann D, Smith AD, Holmes C, McGuinness B, Craig D, Warden D, Heun R, Kolsch H, Love S, Kalsheker N, Williams J, Owen MJ, Carrasquillo M, Younkin S, Morgan K, Kehoe PG (2011) A multi-center study of ACE and the risk of late-onset Alzheimer’s disease. J Alzheimers Dis 24(3):587–597. doi:10.3233/jad-2011-101914
Bertram L, Tanzi RE (2008) Thirty years of Alzheimer’s disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 9(10):768–778. doi:10.1038/nrn2494
Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39(1):17–23. doi:10.1038/ng1934
Bruandet A, Richard F, Tzourio C, Berr C, Dartigues JF, Alperovitch A, Amouyel P, Helbecque N (2008) Haplotypes across ACE and the risk of Alzheimer’s disease: the three-city study. J Alzheimers Dis 13(3):333–339
Casas JP, Hingorani AD, Bautista LE, Sharma P (2004) Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 61(11):1652–1661. doi:10.1001/archneur.61.11.1652
Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, Engel A, Nalls MA, Chen K, Lee W, Chewning K, Villa SE, Meechoovet HB, Gerber JD, Frost D, Benson HL, O’Reilly S, Chibnik LB, Shulman JM, Singleton AB, Craig DW, Van Keuren-Jensen KR, Dunckley T, Bennett DA, De Jager PL, Heward C, Hardy J, Reiman EM, Huentelman MJ (2010) Association of CR1, CLU and PICALM with Alzheimer’s disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet 19(16):3295–3301. doi:10.1093/hmg/ddq221
Cousin E, Mace S, Rocher C, Dib C, Muzard G, Hannequin D, Pradier L, Deleuze JF, Genin E, Brice A, Campion D (2011) No replication of genetic association between candidate polymorphisms and Alzheimer’s disease. Neurobiol Aging 32(8):1443–1451. doi:10.1016/j.neurobiolaging.2009.09.004
DerSimonian R, Kacker R (2007) Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28(2):105–114. doi:10.1016/j.cct.2006.04.004
Edwards TL, Pericak-Vance M, Gilbert JR, Haines JL, Martin ER, Ritchie MD (2009) An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3. Am J Med Genet B Neuropsychiatr Genet 150b(5):721–735. doi:10.1002/ajmg.b.30899
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634
Elias-Sonnenschein LS, Bertram L, Visser PJ (2012) Relationship between genetic risk factors and markers for Alzheimer’s disease pathology. Biomark Med 6(4):477–495. doi:10.2217/bmm.12.56
Feulner TM, Laws SM, Friedrich P, Wagenpfeil S, Wurst SH, Riehle C, Kuhn KA, Krawczak M, Schreiber S, Nikolaus S, Forstl H, Kurz A, Riemenschneider M (2010) Examination of the current top candidate genes for AD in a genome-wide association study. Mol Psychiatry 15(7):756–766. doi:10.1038/mp.2008.141
Genin E, Hannequin D, Wallon D, Sleegers K, Hiltunen M, Combarros O, Bullido MJ, Engelborghs S, De Deyn P, Berr C, Pasquier F, Dubois B, Tognoni G, Fievet N, Brouwers N, Bettens K, Arosio B, Coto E, Del Zompo M, Mateo I, Epelbaum J, Frank-Garcia A, Helisalmi S, Porcellini E, Pilotto A, Forti P, Ferri R, Scarpini E, Siciliano G, Solfrizzi V, Sorbi S, Spalletta G, Valdivieso F, Vepsalainen S, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Hanon O, Piccardi P, Annoni G, Seripa D, Galimberti D, Licastro F, Soininen H, Dartigues JF, Kamboh MI, Van Broeckhoven C, Lambert JC, Amouyel P, Campion D (2011) APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry 16(9):903–907. doi:10.1038/mp.2011.52
Ghebranious N, Mukesh B, Giampietro PF, Glurich I, Mickel SF, Waring SC, McCarty CA (2011) A pilot study of gene/gene and gene/environment interactions in Alzheimer disease. Clin Med Res 9(1):17–25. doi:10.3121/cmr.2010.894
Ghosh D (2012) Incorporating the empirical null hypothesis into the Benjamini-Hochberg procedure. Stat Appl Genet Mol Biol. doi:10.1515/1544-6115.1735
Giedraitis V, Kilander L, Degerman-Gunnarsson M, Sundelof J, Axelsson T, Syvanen AC, Lannfelt L, Glaser A (2009) Genetic analysis of Alzheimer’s disease in the Uppsala longitudinal study of adult men. Dement Geriatr Cogn Disord 27(1):59–68. doi:10.1159/000191203
Hedges LV, Pigott TD (2004) The power of statistical tests for moderators in meta-analysis. Psychol Methods 9(4):426–445. doi:10.1037/1082-989x.9.4.426
Helbecque N, Codron V, Cottel D, Amouyel P (2009) An age effect on the association of common variants of ACE with Alzheimer’s disease. Neurosci Lett 461(2):181–184. doi:10.1016/j.neulet.2009.06.006
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558. doi:10.1002/sim.1186
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560. doi:10.1136/bmj.327.7414.557
Kauwe JS, Wang J, Mayo K, Morris JC, Fagan AM, Holtzman DM, Goate AM (2009) Alzheimer’s disease risk variants show association with cerebrospinal fluid amyloid beta. Neurogenetics 10(1):13–17. doi:10.1007/s10048-008-0150-4
Kehoe PG, Katzov H, Feuk L, Bennet AM, Johansson B, Wiman B, de Faire U, Cairns NJ, Wilcock GK, Brookes AJ, Blennow K, Prince JA (2003) Haplotypes extending across ACE are associated with Alzheimer’s disease. Hum Mol Genet 12(8):859–867
Kehoe PG, Katzov H, Andreasen N, Gatz M, Wilcock GK, Cairns NJ, Palmgren J, de Faire U, Brookes AJ, Pedersen NL, Blennow K, Prince JA (2004) Common variants of ACE contribute to variable age-at-onset of Alzheimer’s disease. Hum Genet 114(5):478–483. doi:10.1007/s00439-004-1093-y
Kehoe PG, Miners S, Love S (2009) Angiotensins in Alzheimer’s disease–friend or foe? Trends Neurosci 32(12):619–628. doi:10.1016/j.tins.2009.07.006
Kim TH, Chang HS, Park SM, Nam BY, Park JS, Rhim T, Park HS, Kim MK, Choi IS, Cho SH, Chung IY, Park BL, Park CS, Shin HD (2008) Association of angiotensin I-converting enzyme gene polymorphisms with aspirin intolerance in asthmatics. Clin Exp Allergy 38(11):1727–1737. doi:10.1111/j.1365-2222.2008.03082.x
Lambert J-C, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, Jun G, DeStefano AL, Bis JC, Beecham GW (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45(12):1452–1458. doi:10.1038/ng.2802
Langan D, Higgins JP, Gregory W, Sutton AJ (2012) Graphical augmentations to the funnel plot assess the impact of additional evidence on a meta-analysis. J Clin Epidemiol 65(5):511–519. doi:10.1016/j.jclinepi.2011.10.009
Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC (1992) Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 327(4):248–254. doi:10.1056/nejm199207233270406
Lee JH, Schell MJ, Roetzheim R (2009) Analysis of group randomized trials with multiple binary endpoints and small number of groups. PLoS One 4(10):e7265. doi:10.1371/journal.pone.0007265
Lehmann DJ, Cortina-Borja M, Warden DR, Smith AD, Sleegers K, Prince JA, van Duijn CM, Kehoe PG (2005) Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer’s disease. Am J Epidemiol 162(4):305–317. doi:10.1093/aje/kwi202
McKenzie CA, Sinsheimer JS, Adeyemo AA, Cox RD, Southam L, Hugill A, Bouzekri N, Lathrop M, Forrester TE, Cooper RS, Ward R (2005) SNP haplotypes in the angiotensin I-converting enzyme (ACE) gene: analysis of Nigerian family data using gamete competition models. Ann Hum Genet 69(Pt 2):227–232. doi:10.1046/j.1529-8817.2004.00142.x
Meng Y, Baldwin CT, Bowirrat A, Waraska K, Inzelberg R, Friedland RP, Farrer LA (2006) Association of polymorphisms in the angiotensin-converting enzyme gene with Alzheimer disease in an Israeli Arab community. Am J Hum Genet 78(5):871–877. doi:10.1086/503687
Miners S, Ashby E, Baig S, Harrison R, Tayler H, Speedy E, Prince JA, Love S, Kehoe PG (2009) Angiotensin-converting enzyme levels and activity in Alzheimer’s disease: differences in brain and CSF ACE and association with ACE1 genotypes. Am J Transl Res 1(2):163–177
Mucke L (2009) Neuroscience: alzheimer’s disease. Nature 461(7266):895–897. doi:10.1038/461895a
Munafo MR, Flint J (2004) Meta-analysis of genetic association studies. Trends Genet 20(9):439–444. doi:10.1016/j.tig.2004.06.014
Ning M, Yang Y, Zhang Z, Chen Z, Zhao T, Zhang D, Zhou D, Xu J, Liu Z, Wang Y, Liu Y, Zhao X, Li W, Li S, He L (2010) Amyloid-beta-Related Genes SORL1 and ACE are genetically associated with risk for late-onset Alzheimer disease in the Chinese population. Alzheimer Dis Assoc Disord 24(4):390–396. doi:10.1097/WAD.0b013e3181e6a575
Ntais C, Polycarpou A, Ioannidis JP (2004) Meta-analysis of the association of the cathepsin D Ala224Val gene polymorphism with the risk of Alzheimer’s disease: a HuGE gene-disease association review. Am J Epidemiol 159(6):527–536
Pedersen NL (2010) Reaching the limits of genome-wide significance in Alzheimer disease: back to the environment. JAMA 303(18):1864–1865. doi:10.1001/jama.2010.609
Prince JA, Feuk L, Sawyer SL, Gottfries J, Ricksten A, Nagga K, Bogdanovic N, Blennow K, Brookes AJ (2001) Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer’s disease. Eur J Hum Genet 9(6):437–444. doi:10.1038/sj.ejhg.5200651
Sarajarvi T, Helisalmi S, Antikainen L, Makinen P, Koivisto AM, Herukka SK, Haapasalo A, Soininen H, Hiltunen M (2010) An association study of 21 potential Alzheimer’s disease risk genes in a Finnish population. J Alzheimers Dis 21(3):763–767. doi:10.3233/jad-2010-100597
Saunders AM (2001) Gene identification in Alzheimer’s disease. Pharmacogenomics 2(3):239–249. doi:10.1517/14622416.2.3.239
Schjeide BM, McQueen MB, Mullin K, DiVito J, Hogan MF, Parkinson M, Hooli B, Lange C, Blacker D, Tanzi RE, Bertram L (2009) Assessment of Alzheimer’s disease case-control associations using family-based methods. Neurogenetics 10(1):19–25. doi:10.1007/s10048-008-0151-3
Schmidt C, Wolff M, von Ahsen N, Zerr I (2012) Alzheimer’s disease: genetic polymorphisms and rate of decline. Dement Geriatr Cogn Disord 33(2–3):84–89. doi:10.1159/000336790
Selkoe DJ (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 192(1):106–113. doi:10.1016/j.bbr.2008.02.016
Shulman JM, Chibnik LB, Aubin C, Schneider JA, Bennett DA, De Jager PL (2010) Intermediate phenotypes identify divergent pathways to Alzheimer’s disease. PLoS One 5(6):e11244. doi:10.1371/journal.pone.0011244
Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605. doi:10.1007/s10654-010-9491-z
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283(15):2008–2012
Thornton-Wells TA, Moore JH, Martin ER, Pericak-Vance MA, Haines JL (2008) Confronting complexity in late-onset Alzheimer disease: application of two-stage analysis approach addressing heterogeneity and epistasis. Genet Epidemiol 32(3):187–203. doi:10.1002/gepi.20294
Wang F, Shu C, Jia L, Zuo X, Zhang Y, Zhou A, Qin W, Song H, Wei C, Zhang F, Hong Z, Tang M, Wang DM, Jia J (2012) Exploration of 16 candidate genes identifies the association of IDE with Alzheimer’s disease in Han Chinese. Neurobiol Aging 33(5):1014.e1011–1014.e1019. doi:10.1016/j.neurobiolaging.2010.08.004
Zintzaras E, Rodopoulou P, Sakellaridis N (2009) Variants of the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and risk of stroke: a HuGE gene-disease association review and meta-analysis. Am J Epidemiol 169(5):523–532. doi:10.1093/aje/kwn368
Acknowledgments
This study was supported by Grants from the National Basic Research Program of China (973 Program, 2012CB720600).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wang, XB., Cui, NH., Gao, JJ. et al. Angiotensin-converting enzyme gene polymorphisms and risk for sporadic Alzheimer’s disease: a meta-analysis. J Neural Transm 122, 211–224 (2015). https://doi.org/10.1007/s00702-014-1235-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-014-1235-x